Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
Diseases of the Digestive System - Small Intestines, Large Intestines & Rectum
What is the purpose of this trial?
Yale is participating in this phase III research study that is testing a new stem cell therapy treatment for perianal fistulas with Crohn’s Disease.
You may qualify if:
- You are between the ages of 18 to 75
- Have been diagnosed with Crohn’s Disease for at least 6 months
- Are not having symptoms of Crohn’s Disease but have perianal fistula(s) that have not responded to treatment
- Ages18 years and older
- Trial withTiGenix S.A.U.
- Start Date12/06/2019
- End Date10/01/2021
- Last Updated09/27/2021
- Study HIC#2000025172